Антифосфолипидный синдром у детей
DOI:
https://doi.org/10.15574/PP.2018.76.93Ключевые слова:
антифосфолипидный синдром, детиАннотация
Приведены современные данные про распространенность антифосфолипидного синдрома у детей. Проведен анализ особенностей клинического течения синдрома детей и уточнены лабораторные критерии диагностики заболевания. Обсуждены проблемы ведения детей с антифосфолипидным синдромом и возможные пути их решения.
Библиографические ссылки
Aguiar CL, Soybilgic A, Avcin T, Myones BL. (2015). Pediatric antiphospholipid syndrome. Current rheumatology reports. 17(4): 27. https://doi.org/10.1007/s11926-015-0504-5; PMid:25854492
Avcin T, Cimaz R, Silverman ED et al. (2007). Register for pediatric patients withantiphospholipid syndrome: clinical and immunological features of 107 children. Arthritis Rheum. 56: S830.
Avcin T. (2008). Antiphospholipid syndrome in children. Current opinion in rheumatology. 20(5): 595—600. https://doi.org/10.1097/BOR.0b013e3283060a8c; PMid:18698184
Avcin T, Silverman ED. (2007). Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus. 16: 627—633. https://doi.org/10.1177/0961203307079036; PMid:17711899
Berkun Y, Simchen MJ, Strauss T, Menashcu S, Padeh S, Kenet G. (2014). Antiphospholipid antibodies in neonates with stroke — a unique entity or variant of antiphospholipid syndrome? Lupus. 23(10): 986—993. https://doi.org/10.1177/0961203314531842; PMid:24729280
Cimaz R, Descloux E. (2006). Pediatric antiphospholipid syndrome. Rheumatic Disease Clinics. 32(3): 553—573. https://doi.org/10.1016/j.rdc.2006.05.005; PMid:16880084
Erkan D, Harrison MJ, Levy R. (2007). Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 56(7): 2382—2391. https://doi.org/10.1002/art.22663; PMid:17599766
Go EL, O'Neil KM. (2017). The catastrophic antiphospholipid syndrome in children. Curr Opin Rheumatol. 29(00). https://doi.org/10.1097/BOR.0000000000000426
Groot N, De Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, McCann L. (2017). European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Annals of the rheumatic diseases, annrheumdis-2016. https://doi.org/10.1136/annrheumdis-2016-211001
Meroni PL, Argolini LM, Pontikaki I. (2016). What is known about pediatric antiphospholipid syndrome? Expert review of hematology. 9(10): 977—985. https://doi.org/10.1080/17474086.2016.1235969; PMid:27615277
Mukherjee SS, Dhar S, Gaikwad RP, Saha A. (2015). Antiphospholipid antibody syndrome in pediatric population: An overview. Indian Journal of Paediatric Dermatology. 16(1): 5. https://doi.org/10.4103/2319-7250.149401
Rao AAN, Elwood K, Kaur D, Warad DM, Rodriguez V. (2017). A retrospective review of pediatric antiphospholipid syndrome and thrombosis outcomes. Blood Coagulation & Fibrinolysis. 28(3): 205—210. https://doi.org/10.1097/MBC.0000000000000576; PMid:27428014
Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I. (2011). Еvidence based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients:report of a task force at the 13th International Congress onantiphospholipid antibodies. Lupus. 20(2): 206—218. https://doi.org/10.1177/0961203310395803; PMid:21303837
Rumsey DG, Myones B, Massicotte P. (2017). Diagnosis and treatment of antiphospholipid syndrome in childhood: A review. Blood Cells, Molecules, and Diseases. 67: 34—40. https://doi.org/10.1016/j.bcmd.2017.02.009; PMid:28283251
